Analyzing MRNA’s current quarter earnings projections

Moderna Inc (MRNA)’s stock has witnessed a price hike of 0.78% from the previous close with its current price standing at $24.66. Its current price is -69.16% under its 52-week high of $79.96 and 6.52% more than its 52-week low of $23.15. Based on the past 30-day period, the stock price is -13.78% below the high and +5.66% above the low.

The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, MRNA’s SMA-200 is $31.78.

Additionally, it is important to take into account MRNA stock ratios, including its price-to-sales ratio, which is 3.12 for the last tewlve months.MRNA’s price to book ratio for the most recent quarter was 1.02, resulting in an 1.87 price to cash per share for the period.

How does Moderna Inc (MRNA) stock rate among analysts? Buy, sell, or hold?

The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 26 brokerage firms that recommend the stock as a Hold. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 2.96 in simple terms.

Moderna Inc (MRNA): Earnings History

If we examine Moderna Inc’s recent earnings history, in the last quarter ended on 6/30/2025, it posted adjusted earnings per share of -$2.13, slashing the consensus of -$2.97. In other words, it beat the consensus by $0.84, resulting in a 28.28% surprise. In the 3 months period before the previous quarter which was closed on 6/30/2025, the stock recorded adjusted earnings per share of -$2.13 in contrast with the Outlook of -$2.97. That was a difference of $0.84 and a surprise of 28.28%.

Moderna Inc (MRNA): Earnings History

Most analysts expect public companies to report earnings and revenue in line with their projections, but sometimes these figures vary from what they actually expected. In the current quarter, the company had earnings predictions made by 11 different analysts, who are expecting earnings to fall in between the range of -0.75 and -2.68 with an average Earnings Estimate of -1.94 which is in contrast with the last year earnings estimate of 0.03 and also replicates -6,566.67% growth rate year over year.

Moderna Inc (NASDAQ: MRNA) Ownership Details

I will give a breakdown of the key shareholders in Moderna Inc (MRNA). Recent figures show that the company’s insiders hold 7.24% of shares. A total of 1,023 institutional investors hold shares in the company, making 74.89% of its stock and 80.74% of its float.

Jun 30, 2025, it was reported that the Company’s largest institutional holder is VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund holding total of 11.19 shares that make 2.88% of the company’s total number of shares and are currently priced at 275.89 million.

The securities firm VANGUARD INDEX FUNDS-Vanguard 500 Index Fund holds 9.66 shares of MRNA, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 2.48%, and the holding percentage of shares is valued at 238.15 million.

An overview of Moderna Inc’s technicals

In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Moderna Inc (MRNA) traded 9,568,826 shares per day, with a moving average of $25.67 and price change of -0.77. With the moving average of $28.68 and a price change of -2.70, about 9,365,454 shares changed hands on average over the past 50 days. Finally, MRNA’s 100-day average volume is 10,118,978 shares, alongside a moving average of $27.55 and a price change of -0.30.

Hot this week

Will Vimeo Inc (VMEO) meet earnings estimates this quarter?

Currently, Vimeo Inc's (VMEO) stock is trading at $7.75,...

A look at BBWI’s current quarter earnings estimates

In the current trading session, Bath & Body Works...

How analysts predict Under Armour Inc (UAA) will perform this quarter?

Under Armour Inc (UAA)'s stock is trading at $4.99...

CAVA stock’s current quarter earnings estimates: What analysts predict?

Cava Group Inc (CAVA)'s stock has witnessed a price...

What to expect from Pure Storage Inc’s (PSTG) current quarter earnings?

Currently, Pure Storage Inc's (PSTG) stock is trading at...

Topics

Will Vimeo Inc (VMEO) meet earnings estimates this quarter?

Currently, Vimeo Inc's (VMEO) stock is trading at $7.75,...

A look at BBWI’s current quarter earnings estimates

In the current trading session, Bath & Body Works...

How analysts predict Under Armour Inc (UAA) will perform this quarter?

Under Armour Inc (UAA)'s stock is trading at $4.99...

CAVA stock’s current quarter earnings estimates: What analysts predict?

Cava Group Inc (CAVA)'s stock has witnessed a price...

What to expect from Pure Storage Inc’s (PSTG) current quarter earnings?

Currently, Pure Storage Inc's (PSTG) stock is trading at...

CCJ’s price-to-cash ratio: How it affects the stock’s valuation.

In the current trading session, Cameco Corp's (CCJ) stock...

Understanding ALIT’s book value per share for better investment insights

Alight Inc (ALIT)'s stock is trading at $3.64 at...

MRVL’s price-to-free cash flow ratio: A closer look at its relevance

Marvell Technology Inc (MRVL)'s stock has witnessed a price...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.